AngioDynamics Statistics
Share Statistics
AngioDynamics has 40.61M
shares outstanding. The number of shares has increased by 1.03%
in one year.
| Shares Outstanding | 40.61M |
| Shares Change (YoY) | 1.03% |
| Shares Change (QoQ) | -0.41% |
| Owned by Institutions (%) | 80.7% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 6,928 |
| FTD / Avg. Volume | 1.38% |
Short Selling Information
The latest short interest is 1.49M, so 3.68% of the outstanding
shares have been sold short.
| Short Interest | 1.49M |
| Short % of Shares Out | 3.68% |
| Short % of Float | 4.48% |
| Short Ratio (days to cover) | 5.28 |
Valuation Ratios
The PE ratio is -1.38 and the forward
PE ratio is -41.39.
AngioDynamics's PEG ratio is
-0.01.
| PE Ratio | -1.38 |
| Forward PE | -41.39 |
| PS Ratio | 0.83 |
| Forward PS | 1 |
| PB Ratio | 1.23 |
| P/FCF Ratio | -7.47 |
| PEG Ratio | -0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for AngioDynamics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.12,
with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.12 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | -0.41 |
| Debt / FCF | -0.17 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $406,302.14 |
| Profits Per Employee | $-246,455.88 |
| Employee Count | 748 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 2.46 |
Taxes
| Income Tax | -7.29M |
| Effective Tax Rate | 3.8% |
Stock Price Statistics
The stock price has increased by 51.42% in the
last 52 weeks. The beta is 0.58, so AngioDynamics's
price volatility has been higher than the market average.
| Beta | 0.58 |
| 52-Week Price Change | 51.42% |
| 50-Day Moving Average | 9.46 |
| 200-Day Moving Average | 8.7 |
| Relative Strength Index (RSI) | 53.44 |
| Average Volume (20 Days) | 501,063 |
Income Statement
In the last 12 months, AngioDynamics had revenue of 303.91M
and earned -184.35M
in profits. Earnings per share was -4.59.
| Revenue | 303.91M |
| Gross Profit | 154.7M |
| Operating Income | -192.44M |
| Net Income | -184.35M |
| EBITDA | -14.29M |
| EBIT | -33.84M |
| Earnings Per Share (EPS) | -4.59 |
Full Income StatementBalance Sheet
The company has 76.06M in cash and 5.91M in
debt, giving a net cash position of 70.14M.
| Cash & Cash Equivalents | 76.06M |
| Total Debt | 5.91M |
| Net Cash | 70.14M |
| Retained Earnings | -395.2M |
| Total Assets | 285.42M |
| Working Capital | 94.3M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -28.16M
and capital expenditures -5.77M, giving a free cash flow of -33.93M.
| Operating Cash Flow | -28.16M |
| Capital Expenditures | -5.77M |
| Free Cash Flow | -33.93M |
| FCF Per Share | -0.84 |
Full Cash Flow StatementMargins
Gross margin is 50.9%, with operating and profit margins of -63.32% and -60.66%.
| Gross Margin | 50.9% |
| Operating Margin | -63.32% |
| Pretax Margin | -63.06% |
| Profit Margin | -60.66% |
| EBITDA Margin | -4.7% |
| EBIT Margin | -63.32% |
| FCF Margin | -11.16% |
